Pacira BioSciences (PCRX) Total Non-Current Liabilities (2010 - 2026)
Pacira BioSciences' Total Non-Current Liabilities was $545.35 million in Q2 2026, down 27.7% from $754.34 million a year earlier but up 2.9% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Total Non-Current Liabilities at Pacira BioSciences came in at $551.23 million, down 27.3% from FY2024.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $758.35 million in FY2024 (+9.8%), $690.68 million in FY2023 (-23.0%), $896.52 million in FY2022 (-32.3%) and $1.32 billion in FY2021 (+103.5%).
- Quarterly Total Non-Current Liabilities has moved between $530.03 million (Q1 2026) and $1.32 billion (Q4 2021) over five years.
- Compared with a year earlier, Total Non-Current Liabilities has declined for four straight quarters, with an average decline of 10.2% over the last eight quarters.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q4 2021 (growth of 103.5%); the worst was Q1 2023 (a decline of 36.5%).
- Per Business Quant data, PCRX's Total Non-Current Liabilities in the three quarters before Q2 2026 was $530.03 million (Q1 2026), $551.23 million (Q4 2025) and $545.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.56 Bn | 1,136.14 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 635.76 Bn | 554.29 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.27 Bn | 476.38 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 377.51 Bn | 331.89 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 304.07 Bn | 268.06 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.22 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 242.06 Bn | 197.46 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.26 Bn | 168.46 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 172.62 Bn | 119.27 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Pacira BioSciences | 1.44 Bn | 497.46 Mn | 148.24 Mn | 545.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 545.35 Mn |
| Mar 31, 2026 | 530.03 Mn |
| Dec 31, 2025 | 551.23 Mn |
| Sep 30, 2025 | 545.06 Mn |
| Jun 30, 2025 | 754.34 Mn |
| Mar 31, 2025 | 764.26 Mn |
| Dec 31, 2024 | 758.35 Mn |
| Sep 30, 2024 | 759.32 Mn |
| Jun 30, 2024 | 754.54 Mn |
| Mar 31, 2024 | 678.47 Mn |
| Dec 31, 2023 | 690.68 Mn |
| Sep 30, 2023 | 690.97 Mn |
| Jun 30, 2023 | 722.62 Mn |
| Mar 31, 2023 | 743.80 Mn |
| Dec 31, 2022 | 896.52 Mn |
| Sep 30, 2022 | 945.13 Mn |
| Jun 30, 2022 | 957.88 Mn |
| Mar 31, 2022 | 1.17 Bn |
| Dec 31, 2021 | 1.32 Bn |
| Sep 30, 2021 | 629.85 Mn |
API Access
Pacira BioSciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();